These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27757967)

  • 1. Diet-induced non-alcoholic fatty liver disease affects expression of major cytochrome P450 genes in a mouse model.
    Chiba T; Noji K; Shinozaki S; Suzuki S; Umegaki K; Shimokado K
    J Pharm Pharmacol; 2016 Dec; 68(12):1567-1576. PubMed ID: 27757967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of cytochrome P450 in nonalcoholic fatty liver induced by high-fat diet: a gene expression profile analysis].
    Liu Y; Cheng F; Luo YX; Hu P; Ren H; Peng ML
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):285-290. PubMed ID: 28494548
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of High-fat and High-cholesterol Diet on Major CYP Activities in the Liver].
    Suzuki S; Sato Y; Umegaki K; Chiba T
    Yakugaku Zasshi; 2016; 136(9):1297-305. PubMed ID: 27592832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coleus forskohlii Extract Attenuated the Beneficial Effect of Diet-Treatment on NASH in Mouse Model.
    Suzuki S; Nishijima C; Sato Y; Umegaki K; Murata M; Chiba T
    J Nutr Sci Vitaminol (Tokyo); 2020; 66(2):191-199. PubMed ID: 32350181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of nonalcoholic fatty liver disease-induced drug metabolism by comparative global toxicoproteomics.
    Na AY; Jo JJ; Kwon OK; Shrestha R; Cho PJ; Kim KM; Ki SH; Lee TH; Jeon TW; Jeong TC; Lee S
    Toxicol Appl Pharmacol; 2018 Aug; 352():28-37. PubMed ID: 29792946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
    Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
    Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
    Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total sesquiterpene glycosides from Loquat (Eriobotrya japonica) leaf alleviate high-fat diet induced non-alcoholic fatty liver disease through cytochrome P450 2E1 inhibition.
    Jian T; Ao X; Wu Y; Lv H; Ma L; Zhao L; Tong B; Ren B; Chen J; Li W
    Biomed Pharmacother; 2017 Jul; 91():229-237. PubMed ID: 28458161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds.
    Ragab SM; Abd Elghaffar SKh; El-Metwally TH; Badr G; Mahmoud MH; Omar HM
    Lipids Health Dis; 2015 Jul; 14():83. PubMed ID: 26228038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
    Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
    World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
    Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
    Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-Resveratrol Enhances the Anticoagulant Activity of Warfarin in a Mouse Model.
    Chiba T; Kimura Y; Suzuki S; Tatefuji T; Umegaki K
    J Atheroscler Thromb; 2016 Sep; 23(9):1099-110. PubMed ID: 26947597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats.
    He Q; Li JK; Li F; Li RG; Zhan GQ; Li G; Du WX; Tan HB
    World J Gastroenterol; 2015 Feb; 21(7):2058-66. PubMed ID: 25717238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of liver drug-metabolizing enzymes in a murine model of chronic renal failure.
    Dani M; Boisvert C; Michaud J; Naud J; Lefrançois S; Leblond FA; Pichette V
    Drug Metab Dispos; 2010 Mar; 38(3):357-60. PubMed ID: 20007296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.
    Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J
    Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tetrahydrocurcumin on the profiles of drug-metabolizing enzymes induced by a high fat and high fructose diet in mice.
    Jearapong N; Chatuphonprasert W; Jarukamjorn K
    Chem Biol Interact; 2015 Sep; 239():67-75. PubMed ID: 26102010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S; Hong J; Jeon R; Kim HS
    Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cytochrome P450 2A5 in a C57BL/6J mouse model of nonalcoholic fatty liver disease.
    Li R; Guo G; Cao Y; Wang Y; Liu F; Zhang X
    Pharmacology; 2013; 92(1-2):26-31. PubMed ID: 23867551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.